|
|
||||||||





,
* Division of Dermatology,
Department of Microbiology and Immunology, and
Molecular Biology Institute, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095;
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan;
¶ Department of Dermatology, Skin Research Center, General Infirmary, University of Leeds, Leeds, United Kingdom; and
|| Genentech, South San Francisco, CA 94080
One of the factors that contributes to the pathogenesis of acne is
Propionibacterium acnes; yet, the molecular mechanism by
which P. acnes induces inflammation is not known. Recent
studies have demonstrated that microbial agents trigger cytokine
responses via Toll-like receptors (TLRs). We investigated whether TLR2
mediates P. acnes-induced cytokine production in acne.
Transfection of TLR2 into a nonresponsive cell line was sufficient for
NF-
B activation in response to P. acnes. In addition,
peritoneal macrophages from wild-type, TLR6 knockout, and TLR1 knockout
mice, but not TLR2 knockout mice, produced IL-6 in response to
P. acnes. P. acnes also induced
activation of IL-12 p40 promoter activity via TLR2. Furthermore,
P. acnes induced IL-12 and IL-8 protein production by
primary human monocytes and this cytokine production was inhibited by
anti-TLR2 blocking Ab. Finally, in acne lesions, TLR2 was expressed
on the cell surface of macrophages surrounding pilosebaceous follicles.
These data suggest that P. acnes triggers inflammatory
cytokine responses in acne by activation of TLR2. As such, TLR2 may
provide a novel target for treatment of this common skin
disease.
This article has been cited by other articles:
![]() |
M. Bek-Thomsen, H. B. Lomholt, and M. Kilian Acne is Not Associated with Yet-Uncultured Bacteria J. Clin. Microbiol., October 1, 2008; 46(10): 3355 - 3360. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Liu, J. Phan, D. Tang, M. Kanchanapoomi, B. Hall, S. R. Krutzik, and J. Kim CD209+ Macrophages Mediate Host Defense against Propionibacterium acnes J. Immunol., April 1, 2008; 180(7): 4919 - 4923. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lodes, H. Secrist, D. R. Benson, S. Jen, K. D. Shanebeck, J. Guderian, J.-F. Maisonneuve, A. Bhatia, D. Persing, S. Patrick, et al. Variable expression of immunoreactive surface proteins of Propionibacterium acnes Microbiology, December 1, 2006; 152(12): 3667 - 3681. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Romics Jr, A. Dolganiuc, A. Velayudham, K. Kodys, P. Mandrekar, D. Golenbock, E. Kurt-Jones, and G. Szabo Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes J. Leukoc. Biol., December 1, 2005; 78(6): 1255 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Cole, H.-H. Mu, N. D. Pennock, A. Hasebe, F. V. Chan, L. R. Washburn, and M. R. Peltier Isolation and Partial Purification of Macrophage- and Dendritic Cell-Activating Components from Mycoplasma arthritidis: Association with Organism Virulence and Involvement with Toll-Like Receptor 2 Infect. Immun., September 1, 2005; 73(9): 6039 - 6047. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kalis, M. Gumenscheimer, N. Freudenberg, S. Tchaptchet, G. Fejer, A. Heit, S. Akira, C. Galanos, and M. A. Freudenberg Requirement for TLR9 in the Immunomodulatory Activity of Propionibacterium acnes J. Immunol., April 1, 2005; 174(7): 4295 - 4300. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Liu, S. R. Krutzik, J. Kim, and R. L. Modlin Cutting Edge: All-trans Retinoic Acid Down-Regulates TLR2 Expression and Function J. Immunol., March 1, 2005; 174(5): 2467 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, M. Walsh, A. V. Villarino, L. Cervi, C. A. Hunter, Y. Choi, and E. J. Pearce TLR Ligands Can Activate Dendritic Cells to Provide a MyD88-Dependent Negative Signal for Th2 Cell Development J. Immunol., January 15, 2005; 174(2): 742 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Torres, M. Barrier, F. Bihl, V. J. F. Quesniaux, I. Maillet, S. Akira, B. Ryffel, and F. Erard Toll-Like Receptor 2 Is Required for Optimal Control of Listeria monocytogenes Infection Infect. Immun., April 1, 2004; 72(4): 2131 - 2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hertz, Q. Wu, E. M. Porter, Y. J. Zhang, K.-H. Weismuller, P. J. Godowski, T. Ganz, S. H. Randell, and R. L. Modlin Activation of Toll-Like Receptor 2 on Human Tracheobronchial Epithelial Cells Induces the Antimicrobial Peptide Human {beta} Defensin-2 J. Immunol., December 15, 2003; 171(12): 6820 - 6826. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |